Tirzepatide 2.5–15 mg/dose — Compounded Subcutaneous Injection Patient Monograph
Patient education monograph for Tirzepatide (2.5–15 mg/dose), a compounded subcutaneous injection. Learn how it works, how to use it, possible side effects, and find a licensed compounding pharmacy near you.
What is Tirzepatide?
This compounded preparation contains tirzepatide, a dual GIP/GLP-1 receptor agonist, prepared by a licensed compounding pharmacy pursuant to an individual patient prescription.
How does Tirzepatide work?
Tirzepatide activates both GIP and GLP-1 hormone receptors, providing a dual action that reduces appetite, slows digestion, and improves insulin sensitivity. This dual mechanism may produce greater weight reduction than single-receptor agents.
How to use Tirzepatide
Inject subcutaneously once weekly as prescribed. Common sites include the abdomen, thigh, or upper arm. Rotate sites with each injection. Administer on the same day each week.
Tirzepatide side effects
Nausea, diarrhea, vomiting, constipation, and injection site reactions are common. Appetite suppression is intended. These effects are usually most noticeable when starting or escalating the dose and typically improve over time.
Drug interactions with Tirzepatide
May delay absorption of oral medications. Use caution with insulin or sulfonylureas due to low blood sugar risk. Inform your prescriber of all medications, supplements, and any over-the-counter drugs you take.
How to store Tirzepatide
Refrigerate at 36°F–46°F (2°C–8°C). Do not freeze. Protect from light. Discard any unused portion per your pharmacy's instructions.
Precautions for Tirzepatide
Notify your prescriber of any personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Report any symptoms of pancreatitis immediately. Keep out of reach of children.
Frequently Asked Questions — Tirzepatide
- What is Tirzepatide?
- This compounded preparation contains tirzepatide, a dual GIP/GLP-1 receptor agonist, prepared by a licensed compounding pharmacy pursuant to an individual patient prescription.
- How does Tirzepatide work?
- Tirzepatide activates both GIP and GLP-1 hormone receptors, providing a dual action that reduces appetite, slows digestion, and improves insulin sensitivity. This dual mechanism may produce greater weight reduction than single-receptor agents.
- How do I use Tirzepatide?
- Inject subcutaneously once weekly as prescribed. Common sites include the abdomen, thigh, or upper arm. Rotate sites with each injection. Administer on the same day each week.
- What are the side effects of Tirzepatide?
- Nausea, diarrhea, vomiting, constipation, and injection site reactions are common. Appetite suppression is intended. These effects are usually most noticeable when starting or escalating the dose and typically improve over time.
- Are there drug interactions with Tirzepatide?
- May delay absorption of oral medications. Use caution with insulin or sulfonylureas due to low blood sugar risk. Inform your prescriber of all medications, supplements, and any over-the-counter drugs you take.
- How should I store Tirzepatide?
- Refrigerate at 36°F–46°F (2°C–8°C). Do not freeze. Protect from light. Discard any unused portion per your pharmacy's instructions.
- What precautions should I know about Tirzepatide?
- Notify your prescriber of any personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Report any symptoms of pancreatitis immediately. Keep out of reach of children.
- Where can I get compounded Tirzepatide?
- Tirzepatide is available through licensed compounding pharmacies on the SlimionRX network. Visit slimionrx.com to find a pharmacy near you.